Clinical Trials for Anaplastic Astrocytoma

Find clinical trials for anaplastic astrocytoma. Discover research opportunities and treatment options in your area.

17 Active Trials Found

Showing 17 trials on this page

Page 1 of 1

Targeted Pediatric High-Grade Glioma Therapy

NCT ID: NCT05839379

This clinical trial, called Targeted Pediatric High-Grade Glioma Therapy, is focused on studying brain tumors in children, adolescents, and young adults who have recently been diagnosed with high-g...

Recruiting

Type: observational Locations: Philadelphia, Pennsylvania, United States, Randwick, New South Wales, Australia +18 more

Study of Ribociclib and Everolimus in HGG and DIPG

NCT ID: NCT05843253

This clinical trial is studying two medications, ribociclib and everolimus, to see if they can help prolong the life of children and young adults newly diagnosed with high-grade gliomas (HGG), incl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Randwick, New South Wales, Australia +18 more

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

NCT ID: NCT06333899

This clinical trial is investigating a medication called lorlatinib to see how well it works in treating children who have newly diagnosed high-grade gliomas, which are aggressive brain tumors. Spe...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Randwick, New South Wales, Australia +16 more

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

NCT ID: NCT06264388

This clinical trial is studying a new treatment approach for patients with high-grade gliomas, specifically recurrent glioblastoma or anaplastic astrocytoma. The treatment combines two investigatio...

Recruiting

Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

NCT ID: NCT05698524

This clinical trial is studying a new treatment approach for patients with recurrent glioma, a type of brain cancer that includes conditions like glioblastoma and anaplastic astrocytoma. It aims to...

Recruiting

Phase: PHASE1 Type: interventional Locations: Omaha, Nebraska, United States

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

NCT ID: NCT04978727

This clinical trial is studying a new treatment for children with certain types of brain tumors, including medulloblastoma and diffuse intrinsic pontine glioma (DIPG). The treatment involves a vacc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Toronto, Ontario, Canada, Palo Alto, California, United States +14 more

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

NCT ID: NCT02800486

This clinical trial is studying a new treatment approach for patients with certain types of brain tumors, specifically recurrent glioblastoma, anaplastic astrocytoma, and anaplastic oligoastrocytom...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

NCT ID: NCT01269853

This clinical trial is studying a treatment called Bevacizumab (also known as Avastin) for patients with relapsed glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA), which are aggressive...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

NCT ID: NCT05956821

This clinical trial is exploring a new treatment for young patients under 22 years old who have certain types of brain tumors, specifically those that have come back or haven’t responded to previou...

Recruiting

Phase: PHASE1 Type: interventional Locations: Miami, Florida, United States

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

NCT ID: NCT04541082

This clinical trial is investigating a new medication called ONC206, taken by mouth, for patients with certain types of brain tumors that have come back after treatment. The main goal of the study ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

Study of Pembrolizumab and M032 (NSC 733972)

NCT ID: NCT05084430

This clinical trial is studying the combination of two treatments, Pembrolizumab and M032, for patients with certain types of brain tumors such as glioblastoma multiforme, anaplastic astrocytoma, a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Birmingham, Alabama, United States

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults with Brain Tumors

NCT ID: NCT05934630

This clinical trial is studying the use of a special test called "liquid biopsy" to find tumor DNA in the cerebrospinal fluid (CSF) of children, adolescents, and young adults with different types o...

Recruiting

Type: observational Locations: New York, New York, United States, Washington, District Of Columbia, United States +6 more

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

NCT ID: NCT03603405

This clinical trial is investigating a new treatment approach for patients with newly diagnosed glioblastoma multiforme (GBM) or anaplastic astrocytoma (AA). The study is looking at a combination o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas

NCT ID: NCT01849952

This clinical trial is studying a specific molecule called microRNA-10b (miRNA-10b) to see how it behaves in patients with different types of brain tumors, including glioblastomas and other gliomas...

Recruiting

Type: observational Locations: Boston, Massachusetts, United States, Lebanon, New Hampshire, United States +2 more

Loupe-Based Intraoperative Fluorescence Imaging

NCT ID: NCT04780009

This clinical trial is studying a new wearable device that uses special imaging technology to help surgeons see brain tumors more clearly during surgery. The main goal is to see if this smaller, ea...

Recruiting

Type: observational Locations: Lexington, Kentucky, United States

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

NCT ID: NCT06108206

This clinical trial is looking at how additional MRI scans can improve radiation treatment for patients with high-grade gliomas, which are aggressive types of brain tumors like glioblastoma and ana...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, New York, New York, United States

Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas

NCT ID: NCT06241391

This clinical trial is studying a new imaging technique called Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT to see how well it can detect recurrent gliomas, which are types of brain tumor...

Not yet recruiting

Phase: NA Type: interventional Locations: Bhubaneswar, Odisha, India

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions